title: [Intoxications by hallucinogenic mushrooms].
abstract: In the context of excessive use of natural or synthetic psychoactive substances, with stimulating, psychedelic and hallucinogenic effects, an increase, if not a recurrence, in consumption of Psilocybe semilanceata has been observed in France over some fifteen years. Psilocybin and psilocin are the active compounds, responsible for the hallucinogenic effects and are a part of the substance group, derived from tryptamine and characterized by an indole nucleus. We report a clinical case observed in an emergency unit and review the historical, epidemiological and pharmacological data now available for these intoxications. Of particular interests in hallucinogenic mushroom abuse are: increased consumption in the context of youth cultural and entertainment movements; possible difficulties in the diagnosis in emergency conditions; possibility of severe and fatal complications.
authors: Centre Anti-Poison, Centre d'Evaluation et d'Information sur la Pharmacodépendance, CHU, 29, avenue Maréchal-de-Lattre-de-Tassigny, CO n degrees 34, 54035 Nancy Cedex.
authors: M
authors: M
authors: Pierrot
authors: P
authors: P
authors: Josse
authors: M F
authors: MF
authors: Raspiller
authors: M
authors: M
authors: Goulmy
authors: M O
authors: MO
authors: Rambourg
authors: J
authors: J
authors: Manel
authors: H
authors: H
authors: Lambert
mesh_terms: D000328:Adult; D005500:Follow-Up Studies; D006213:Hallucinogens / Q000506:poisoning*; D006801:Humans; D008297:Male; D009145:Mushroom Poisoning / Q000175:diagnosis; D011562:Psilocybin / Q000506:poisoning*; D013997:Time Factors
chemical_list: D006213:Hallucinogens; D011562:Psilocybin